Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02114996
Other study ID # B3072
Secondary ID
Status Not yet recruiting
Phase N/A
First received April 13, 2014
Last updated April 13, 2014
Start date April 2014
Est. completion date August 2017

Study information

Verified date April 2014
Source The Baruch Padeh Medical Center, Poriya
Contact n/a
Is FDA regulated No
Health authority Israel: Internal Review Board of the Baruch Padeh Poria Medical Center
Study type Observational

Clinical Trial Summary

Vocal stimulation may encourage spontaneous breathing in patients dependent on mechanical ventilation.

The study will include 30 patients on mechanical ventilation that will be intervened by the vocal stimulation and 30 patients on mechanical ventilation will serve as the control group.


Description:

Vocal stimulation may encourage breathing in ventilated patients dependent on mechanical ventilation.

The study will include 30 patients on mechanical ventilation that will be intervened by the vocal stimulation and 30 patients on mechanical ventilation that will be our control group.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date August 2017
Est. primary completion date August 2017
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- ischemic stroke men and women older than 18 years old and younger than 80 years old

Exclusion Criteria:

- coma from other reasons other than ischemic stroke hemmorhagic stroke active malignancy renal failure

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Ischemia
  • Patients Ventilated by Mechanical Ventilation With Ischemic Stroke
  • Stroke

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
The Baruch Padeh Medical Center, Poriya

Outcome

Type Measure Description Time frame Safety issue
Primary spontaneous breathing we anticipate a better response and recurring spontaneous breathing in the treatment group. 3 days No